Actualizado 30/01/2009 10:59
- Comunicado -

ECASS 3 Study Receives Recognition From the European Stroke Organisation and The Lancet (y 2)

Contact: John Pugh, Corporate Division Communications, Boehringer Ingelheim GmbH, 55216 Ingelheim/Germany, E-mail: press@boehringer-ingelheim.com

Contenido patrocinado